跳转至内容
Merck
CN

SAB4200323

Anti-OSTF1 (C-terminal) antibody produced in rabbit

~1.0 mg/mL, affinity isolated antibody

别名:

Anti-OSF1, Anti-Osteoclast-stimulating factor 1

登录 查看组织和合同定价。

选择尺寸


关于此项目

NACRES:
NA.41
UNSPSC Code:
12352203
Conjugate:
unconjugated
Clone:
polyclonal
Application:
WB
Citations:
4
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

biological source

rabbit

conjugate

unconjugated

antibody form

affinity isolated antibody

antibody product type

primary antibodies

clone

polyclonal

form

buffered aqueous solution

mol wt

antigen ~26 kDa

species reactivity

human

concentration

~1.0 mg/mL

technique(s)

western blot: 1-2 μg/mL using lysates of HEK-293T cells over-expressing human OSTF1.

UniProt accession no.

shipped in

dry ice

storage temp.

−20°C

target post-translational modification

unmodified

Gene Information

human ... OSTF1(26578)

General description

Osteoclast-stimulating factor (OSF or OSTF1) gene is mapped to human chromosome 9q21.13 and is expressed in osteoclasts (OCL) as well as motor neurons. OSF is a small intracellular protein and comprises an N-terminal proline-rich region SRC Homology 3 (SH3) domain, three ankyrin repeats and a C-terminal aspartate-rich region. Structurally, OCF protein takes up a β‐barrel fold.

Immunogen

peptide corresponding to the C- terminal region of human OSTF1 conjugated to KLH. The corresponding sequence differs by two or three amino acids in mouse or rat, respectively.

Application

Anti-OSTF1 (C-terminal) antibody produced in rabbit may be used in immunoblotting.

Biochem/physiol Actions

Anti-OSTF1 (C-terminal) recognizes human OSTF1.
Osteoclast-stimulating factor (OSF or OSTF1) SRC Homology 3 (SH3) domain undergoes conformational changes to bind to proline-rich ligand. The C-terminal ankyrin repeats preferably binds to negative-charged binding partners. OSF-SH3 domain interaction stimulates OCL formation and its inhibition may reduce bone resorption by OCL. A compromised bone resorption functionality in OCL further triggers bone loss and may lead to various bone disorders, including hyperparathyroidism, Paget′s disease, osteoporosis, estrogen deficiency, periodontal disease as well as inflammatory bone loss and bone malignancy. OSF favors OCL formation by interacting with sarcoma proto oncogene (c-Src) and its associated proteins based signaling pathway. OSF is implicated in the pathophysiology of spinal muscular atrophy by its possible interaction with survival motor neuron (SMN) proteins through SH3 domain.

Physical form

Solution in 0.01 M phosphate buffered saline, pH 7.4, containing 15 mM sodium azide.

Preparation Note

For continuous use, store at 2-8 °C for up to one month. For extended storage, freeze in working aliquots. Repeated freezing and thawing, or storage in “frost-free” freezers,is not recommended. If slight turbidity occurs upon prolonged storage, clarify the solution by centrifugation before use. Working dilutions should be discarded if not used within 12 hours.

Disclaimer

Unless otherwise stated in our catalog, our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

未找到合适的产品?  

试试我们的产品选型工具.

存储类别

10 - Combustible liquids

flash_point_f

Not applicable

flash_point_c

Not applicable

法规信息

新产品
此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Structure of the SH3 domain of human osteoclast-stimulating factor at atomic resolution
Chen L, et al.
Acta Crystallographica Section F, Structural Biology and Crystallization Communications, 844-844 (2006)
Matthieu Vermeren et al.
Mammalian genome : official journal of the International Mammalian Genome Society, 28(11-12), 498-514 (2017-09-25)
Osteoclast stimulation factor 1 (OSTF1) is an SH3-domain containing protein that was initially identified as a factor involved in the indirect activation of osteoclasts. It has been linked to spinal muscular atrophy in humans through its interaction with SMN1, and
Crystal structure of human osteoclast stimulating factor.
Shuilong Tong et al.
Proteins, 75(1), 245-251 (2009-01-13)
N Kurihara et al.
The Journal of biological chemistry, 276(44), 41035-41039 (2001-09-12)
We have recently identified and cloned an intracellular peptide termed osteoclast-stimulating factor (OSF) that increases osteoclast (OCL) formation and bone resorption through a cellular signal transduction cascade, possibly through its interaction with c-Src or related family members. To further identify

相关内容

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持